Valuation: Becton, Dickinson and Company

Market Cap 57.71B 51.76B 47.31B 43.18B 81.36B 5,425B 83.93B 570B 227B 2,895B 217B 212B 9,138B P/E 2026
43.8x
P/E 2027 * 25x
Enterprise Value 73.6B 66.01B 60.33B 55.07B 104B 6,918B 107B 727B 290B 3,692B 276B 270B 11,654B EV / Sales 2026
2.51x
EV / Sales 2027 * 3.63x
Free-Float
73.18%
Yield 2026 *
1.97%
Yield 2027 * 2.01%
1 day-0.78%
1 week+7.07%
Current month+7.07%
1 month+17.61%
3 months+19.80%
6 months+38.25%
Current year+9.18%
1 week 196.24
Extreme 196.24
214.88
1 month 181.51
Extreme 181.51
214.88
Current year 140.11
Extreme 140.11
214.88
1 year 140.11
Extreme 140.11
214.88
3 years 140.11
Extreme 140.11
251.98
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+7.07%+19.14%-17.27% 57.71B
-3.23%+3.51%-13.00%+15.96% 190B
-2.90%+5.45%+10.41%+40.45% 125B
-2.75%+11.65%-8.47%+18.50% 124B
+0.96%+5.15%-37.16%+12.09% 99.31B
-1.80%+0.82%-7.52%+70.12% 63.65B
+0.79%+22.65%-4.57%+60.02% 53.26B
-6.98%-14.56%-11.97%+46.23% 47.03B
-2.36%+3.72%+3.86%-7.99% 36.15B
-0.30%+23.41% - - 34.83B
Average -1.94%+7.08%-5.48%+26.46% 83.1B
Weighted average by Cap. -2.12%+6.45%-7.49%+25.28%

Financials

2026 2027 *
Net sales 19.29B 17.3B 15.81B 14.43B 27.19B 1,813B 28.05B 191B 76B 968B 72.41B 70.85B 3,054B 19.73B 17.69B 16.17B 14.76B 27.81B 1,855B 28.69B 195B 77.72B 990B 74.05B 72.46B 3,124B
Net income 1.41B 1.26B 1.15B 1.05B 1.98B 132B 2.05B 13.89B 5.54B 70.54B 5.28B 5.17B 223B 2.19B 1.97B 1.8B 1.64B 3.09B 206B 3.19B 21.66B 8.64B 110B 8.23B 8.05B 347B
Net Debt 15.88B 14.25B 13.02B 11.89B 22.39B 1,493B 23.1B 157B 62.58B 797B 59.62B 58.35B 2,515B 13.95B 12.51B 11.44B 10.44B 19.67B 1,311B 20.29B 138B 54.97B 700B 52.37B 51.24B 2,209B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
60,000
Date Price Change Volume
26-11-06 $211.88 -0.78% 2,172,611
26-11-05 $213.55 +2.08% 3,991,906
26-11-04 $209.19 +5.56% 4,460,588
26-11-03 $198.17 -0.22% 1,957,832
26-11-02 $198.60 +0.36% 1,785,137
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
211.88USD
Average target price
195.57USD
Spread / Average Target
-7.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company